Wibke Bechtel-Walz

Dr. Wibke Bechtel-Walz

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2010 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
WBWibke Bechtel-Walz
Wibke Bechtel-Walz
SMScott McGoohan
Scott McGoohan
EZElisabeth M Zeisberg
Elisabeth M Zeisberg
GMGerhard A Müller
Gerhard A Müller
HKHubert Kalbacher
Hubert Kalbacher
MZMichael Zeisberg
Michael Zeisberg

5 February 2012 in Nature Medicine
Verified
Journal Article
Open access
PDF file
HSHikaru Sugimoto
Hikaru Sugimoto
VLValerie S LeBleu
Valerie S LeBleu
DBDattatreyamurty Bosukonda
Dattatreyamurty Bosukonda
PKPeter Keck
Peter Keck
GTGangadhar Taduri
Gangadhar Taduri
RKRaghu Kalluri
Raghu Kalluri
BMP7 has been previously shown to protect against renal fibrosis. Raghu Kalluri and his colleagues have now identified activin-like kinase 3 (Alk3) as the key co-receptor for BMP7 in the kidney and have identified an orally available, small-peptide agonist of Alk3 that reduces established fibrosis in five animal models of kidney injury. Molecules associated with the transforming growth factor β (TGF-β) superfamily, such as bone morphogenic proteins (BMPs) and TGF-β, are key regulators of inflammation, apoptosis and cellular transitions. Here we show that the BMP receptor activin-like kinase 3 (Alk3) is elevated early in diseased kidneys after injury. We also found that its deletion in the tubular epithelium leads to enhanced TGF-β1–Smad family member 3 (Smad3) signaling, epithelial damage and fibrosis, suggesting a protective role for Alk3-mediated signaling in the kidney. A structure-function analysis of the BMP-Alk3–BMP receptor, type 2 (BMPR2) ligand-receptor complex, along with synthetic organic chemistry, led us to construct a library of small peptide agonists of BMP signaling that function through the Alk3 receptor. One such peptide agonist, THR-123, suppressed inflammation, apoptosis and the epithelial-to-mesenchymal transition program and reversed established fibrosis in five mouse models of acute and chronic renal injury. THR-123 acts specifically through Alk3 signaling, as mice with a targeted deletion for Alk3 in their tubular epithelium did not respond to therapy with THR-123. Combining THR-123 and the angiotensin-converting enzyme inhibitor captopril had an additive therapeutic benefit in controlling renal fibrosis. Our studies show that BMP signaling agonists constitute a new line of therapeutic agents with potential utility in the clinic to induce regeneration, repair and reverse established fibrosis.

1 June 2013 in Kidney International
Verified
Journal Article
Closed access
MBMelanie Boerries
Melanie Boerries
FGFlorian Grahammer
Florian Grahammer
SESven Eiselein
Sven Eiselein
MBMoritz Buck
Moritz Buck
CMCharlotte Meyer
Charlotte Meyer
THTobias B. Huber
Tobias B. Huber

1 May 2013 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
WBWibke Bechtel-Walz
Wibke Bechtel-Walz
MHMartin Helmstädter
Martin Helmstädter
JBJan Balica
Jan Balica
BHBjörn Hartleben
Björn Hartleben
BKBetina Kiefer
Betina Kiefer
THTobias B. Huber
Tobias B. Huber
The molecular mechanisms that maintain podocytes and consequently, the integrity of the glomerular filtration barrier are incompletely understood. Here, we show that the class III phosphoinositide 3-kinase vacuolar protein sorting 34 (Vps34) plays a central role in modulating endocytic pathways, maintaining podocyte homeostasis. In mice, podocyte-specific conditional knockout of Vps34 led to early proteinuria, glomerular scarring, and death within 3–9 weeks of age. Vps34-deficient podocytes exhibited substantial vacuolization and foot process effacement. Although the formation of autophagosomes and autophagic flux were impaired, comparisons between podocyte-specific Vps34-deficient mice, autophagy-deficient mice, and doubly deficient mice suggested that defective autophagy was not primarily responsible for the severe phenotype caused by the loss of Vps34. In fact, Rab5-positive endosomal compartments, endocytosis, and fluid-phase uptake were severely disrupted in Vps34-deficient podocytes. Vps34 deficiency in nephrocytes, the podocyte-like cells of Drosophila melanogaster, resulted in a block between Rab5- and Rab7-positive endosomal compartments. In summary, these data identify Vps34 as a major regulator of endolysosomal pathways in podocytes and underline the fundamental roles of endocytosis and fluid-phase uptake for the maintenance of the glomerular filtration barrier.

1 June 2002 in Carcinogenesis
Verified
Journal Article
Open access
PDF file
SHStefanie Heigold
Stefanie Heigold
CSChristine Sers
Christine Sers
WBWibke Bechtel-Walz
Wibke Bechtel-Walz
BIBoris Ivanovas
Boris Ivanovas
RSReinhold Schäfer
Reinhold Schäfer
GBGeorg Bauer
Georg Bauer
Nitric oxide (NO) mediates apoptosis induction in fibroblasts with constitutive src or induced ras oncogene expression, whereas nontransformed parental cells and revertants are not affected. This direct link between the transformed phenotype and sensitivity to NO-mediated apoptosis induction seems to be based on the recently described extracellular superoxide anion generation by transformed cells, as NO-mediated apoptosis induction in transformed cells is inhibited by extracellular superoxide dismutase (SOD), by SOD mimetics and by apocynin, an inhibitor of NADPH oxidase. Furthermore, nonresponsive nontransformed cells can be rendered sensitive for NO-mediated apoptosis induction when they are supplemented with xanthine oxidase/xanthine as an extracellular source for superoxide anions. As superoxide anions and NO readily interact in a diffusion-controlled reaction to generate peroxynitrite, peroxynitrite seems to be the responsible apoptosis inducer in NO-mediated apoptosis induction. In line with this conclusion, NO-mediated apoptosis induction in superoxide anion-generating transformed cells is inhibited by the peroxynitrite scavengers ebselen and FeTPPS. Moreover, direct application of peroxynitrite induces apoptosis both in transformed and nontransformed cells, indicating that peroxynitrite is no selective apoptosis inducer per se, but that selective apoptosis induction in transformed cells by NO is achieved through selective peroxynitrite generation. The interaction of NO with target cell derived superoxide anions represents a novel concept for selective apoptosis induction in transformed cells. This mechanism may be the basis for selective apoptosis induction by natural antitumor systems (like macrophages, natural killer cells, granulocytes) that utilize NO for antitumor action. Apoptosis induction mediated by NO involves mitochondrial depolarization and is blocked by Bcl-2 overexpression.

1 January 2015 in EBioMedicine
Verified
Journal Article
Open access
BTBjörn Tampe
Björn Tampe
DTDesiree Tampe
Desiree Tampe
EZElisabeth M. Zeisberg
Elisabeth M. Zeisberg
GMGerhard A. Müller
Gerhard A. Müller
WBWibke Bechtel-Walz
Wibke Bechtel-Walz
MZMichael Zeisberg
Michael Zeisberg
Progression of chronic kidney disease remains a principal problem in clinical nephrology and there is a pressing need for novel therapeutics and biomarkers. Aberrant promoter CpG island methylation and subsequent transcriptional silencing of specific genes have emerged as contributors to progression of chronic kidney disease. Here, we report that transcriptional silencing of the Ras-GTP suppressor RASAL1 contributes causally to progression of kidney fibrosis and we identified that circulating methylated RASAL1 promoter DNA fragments in peripheral blood correspond with levels of intrarenal levels of RASAL1 promoter methylation and degree of fibrosis in kidney biopsies, enabling non-invasive longitudinal analysis of intrarenal CpG island methylation.